Does MIRABEGRON Cause Gait inability? 374 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 374 reports of Gait inability have been filed in association with MIRABEGRON (MIRABEGRON). This represents 1.8% of all adverse event reports for MIRABEGRON.
374
Reports of Gait inability with MIRABEGRON
1.8%
of all MIRABEGRON reports
342
Deaths
283
Hospitalizations
How Dangerous Is Gait inability From MIRABEGRON?
Of the 374 reports, 342 (91.4%) resulted in death, 283 (75.7%) required hospitalization, and 278 (74.3%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 374 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which MIRABEGRON Alternatives Have Lower Gait inability Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE